Company Filing History:
Years Active: 2019-2023
Title: Inventor Timo Eichner - Pioneering Innovations in Pharmaceutical Applications
Introduction
Timo Eichner, an accomplished inventor based in Freising, Germany, has made significant contributions to the field of pharmaceuticals with his innovative work. With a total of four patents, his focus lies particularly on developing novel lipocalin muteins that hold promise for medical applications, especially in cancer treatment and immune modulation.
Latest Patents
Eichner's most recent patents focus on lipocalin muteins with a binding affinity for LAG-3, a checkpoint protein that plays a critical role in immune regulation. These human tear lipocalin muteins are designed for pharmaceutical applications, serving as anti-cancer agents and immune modulators. The patents disclose methods for creating these muteins, alongside therapeutic and diagnostic uses, including their ability to inhibit the binding of LAG-3 to MHC class II on cells overexpressing this molecule. These innovations not only contribute toward the prevention and treatment of various human diseases, such as cancer and autoimmune disorders, but also pave the way for developing advanced therapeutic strategies.
Career Highlights
Currently, Timo Eichner is affiliated with Pieris Pharmaceuticals GmbH, where he actively engages in cutting-edge research and development. His work exemplifies a commitment to advancing medical science through the innovation of effective therapeutic agents. Eichner's research has led to substantial advancements in understanding and targeting immune responses, particularly in the context of cancer therapies.
Collaborations
Throughout his career, Eichner has worked closely with talented colleagues, including Christine Rothe and Andrea Allersdorfer. These collaborations have not only enhanced the quality of research but have also facilitated the development of novel therapeutic candidates that cater to pressing medical needs.
Conclusion
In conclusion, Timo Eichner represents a remarkable figure in the realm of innovation, especially in pharmaceuticals. His patented work on lipocalin muteins reflects a deep understanding of immunology and a dedication to improving healthcare outcomes. As the medical field continues to evolve, Eichner's contributions stand out, showcasing the important intersection of invention, research, and practical application in the fight against serious diseases.